Home | Simplified Chinese | Japanese | Korean
English About Changzhou Mayor’s Mailbox Government Bulletin Latest News Laws and Regulations
Genova Biotech successfully financed $50 million
Font:〖L M S

On the afternoon of Dec 5, Genova Biotech (Changzhou) Co., Ltd. signed the Round B financing agreement worth 50 million USD with Tasly Holding Group and BVCF.

Zhou Bin, member of the Standing Committee of CPC Changzhou Municipal Committee and Secretary of CPC Xinbei District Committee, attended the signing ceremony.

Tasly Holding Group is a high-tech international enterprise specializing in health care, medical treatment and health service, which was listed on Shanghai Stock Exchange in 2002.

Genova Biotech is a high-tech enterprise located in Changzhou Life and Health Industrial Park, mainly engaged in the research and manufacturing of insulin analog products. In 2014, it signed the Round A financing agreement worth 20 million USD with BVCF. The 50 million USD financed in Round B will be used in the industrialization of insulin products.

扫一扫在手机打开当前页

 
Sponsored by: General Office and Foreign Affairs Office of Changzhou Municipal People’s Government All rights reserved
苏公网安备32041102000483号 网站标识码:3204000002 苏ICP备05003616号 Technical Support Phone:0519-85685023
Best viewed in IE 6.0 browser with and above 1024*768 resolution.